NCT04695912

Brief Summary

In a cross-over, open-label, randomized, controlled trial, the investigators aim to determine if the daily activity level in patients with LBP can be increased via feedback from an app, connected to a wearable sensor of physical activity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable low-back-pain

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 26, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2019

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

December 8, 2020

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 5, 2021

Completed
Last Updated

January 5, 2021

Status Verified

January 1, 2021

Enrollment Period

2 months

First QC Date

December 8, 2020

Last Update Submit

January 3, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Average daily activity

    The Primary outcome was defined as the difference in average (mean) daily number of minutes in activity (defined as the sum of time spent with standing, walking, cycling and exercising) in 14 days intervention period compared to 14 days control period, registered by the sensor.

    1 month

Study Arms (2)

Initial activity tracker with feedback followed by control period

OTHER

Initial activity tracker with feedback followed by control period

Device: The SENS motion® sensor

Initial control period followed by activity tracker with feedback

OTHER

Initial control period followed by activity tracker with feedback

Device: The SENS motion® sensor

Interventions

The sensor is a wearable physical tracker giving investigators feedback about daily activity The SENS motion® system consists of: The sensor 'SENS Motion Patch' A smart-phone application 'SENS motion´ SENS motion cloud storage database, a web-based visualization of data for the healthcare team The iSpine app shows activity-information recorded by the sensor to the patient and gives nudges to activity.

Also known as: iSpine app (InterMedCon)
Initial activity tracker with feedback followed by control periodInitial control period followed by activity tracker with feedback

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • non-specific low back pain, spinal stenosis, radiculopathy
  • moderate disability or worse (20-100 points on Oswestry Disability Index)

You may not qualify if:

  • co-morbidity making the patients unable to move
  • unsufficient Danish-skills
  • patients who already monitored their activity by watch or phone on a daily basis
  • allergy to band-aid
  • pregnancy or breast-feeding
  • patients referred for back-surgical evaluation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

COPEBACK, Rigshospitalet

Copenhagen, Denmark

Location

MeSH Terms

Conditions

Low Back PainSciatica

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSciatic NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNeuralgia

Study Officials

  • Anna katrine Itenov, MD

    COPEBACK, Rigshospitalet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: crossover, open-label, randomized, controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
senior registrar, MD

Study Record Dates

First Submitted

December 8, 2020

First Posted

January 5, 2021

Study Start

April 26, 2019

Primary Completion

June 20, 2019

Study Completion

June 20, 2019

Last Updated

January 5, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations